MyBiotics Pharma Receives Investment from Mii Fund, an Innovator in the Field of Dermatology
MyBiotics Pharma Receives Investment from Mii Fund, an Innovator in the Field of Dermatology USA - English News provided by Share this article Share this article REHOVOT, Israel, Feb. 3, 2021 /PRNewswire/ -- MyBiotics Pharma, a microbiome therapeutics company, announced today that it has received an investment from Mii Fund, a partnership with Maruho Co. Ltd., Japan's preeminent leader in dermatology. MyBiotics will use the funds to advance its microbiome therapeutics pipeline and continue to enhance its unique microbiome platform technologies. In addition, the company is initiating a develo...
Source: prnewswire.com